Justine O'Brien, Patrizia Colucci, Yolanda Alvarez, Breandán N Kennedy
{"title":"Uncovering Novel Drugs that Restore Vision Using Orthogonal Pooling in Zebrafish.","authors":"Justine O'Brien, Patrizia Colucci, Yolanda Alvarez, Breandán N Kennedy","doi":"10.1007/978-3-031-76550-6_80","DOIUrl":"10.1007/978-3-031-76550-6_80","url":null,"abstract":"<p><p>Photoreceptor and retinal pigment epithelium (RPE) dysfunction in inherited retinal degenerations (IRDs) and age-related macular degeneration (AMD) necessitate innovative therapies to preserve vision. Vision impairment incurs a substantial global economic burden, with the World Health Organization reporting an annual global productivity loss of approximately $411 billion. Current treatments are limited, underscoring the urgency for novel solutions. Leveraging new screening techniques, novel drugs restoring vision can be uncovered. Here, a workflow is described utilising orthogonal pooling to screen randomised library compounds for drug hits restoring vision and assessing the optokinetic response (OKR) in the atp6v0e1<sup>-/-</sup> zebrafish model of inherited blindness.</p>","PeriodicalId":7270,"journal":{"name":"Advances in experimental medicine and biology","volume":"1468 ","pages":"491-495"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143389640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hossein Ameri, Niranjana Kesavamoorthy, Dara N Bruce
{"title":"Frequency and Pattern of Gene Therapy Clinical Trials for Inherited Retinal Diseases.","authors":"Hossein Ameri, Niranjana Kesavamoorthy, Dara N Bruce","doi":"10.1007/978-3-031-76550-6_15","DOIUrl":"10.1007/978-3-031-76550-6_15","url":null,"abstract":"<p><p>This study describes worldwide gene therapy clinical trials aimed at treating inherited retinal diseases (IRD). The information was collected through 15 different international registries including clinicaltrials.gov . There have been 101 gene therapy clinical trials targeting IRD up until the end of 2022. Seventy-seven trials employed gene augmentation using viral vectors; other approaches included inhibitory RNA (9), encapsulated cell technology (6), systemic approach (1), and observational trials (8). The most common clinical trial phase was phase 1/2 (46), followed by phase 3 (12). One trial led to an FDA-approved treatment. Sixty-nine trials were conducted in a single country, and 32 trials were multinational; The USA had the highest share in both categories. Retinitis pigmentosa was the most common disease targeted (39), followed by RPE65-mediated retinal dystrophy (13), Leber hereditary optic neuropathy (13), choroideremia (10 and achromatopsia (8), Leber congenital amaurosis (4), X-linked retinoschisis (4), Stargardt disease (4), Bietti's crystalline dystrophy (2), autosomal dominant optic atrophy (1), and Gyrate atrophy (1). For gene augmentation trials, adeno-associated virus was the most commonly used viral vector (70 trials-90%).</p>","PeriodicalId":7270,"journal":{"name":"Advances in experimental medicine and biology","volume":"1468 ","pages":"89-93"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143389717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Is Caveolin-1 Required for Retinal Neuroprotection?","authors":"Olawale O Bankole, Michael H Elliott","doi":"10.1007/978-3-031-76550-6_47","DOIUrl":"10.1007/978-3-031-76550-6_47","url":null,"abstract":"<p><p>The innate ability to produce neurotrophic cytokines is a crucial component of retinal neuroprotection. Reduced levels of these cytokines accelerate neuronal cell death in the retina during injury but prolonged overexpression can lead to inflammation and retinal damage. It is therefore critical to find molecular targets that regulate the endogenous production of retinal neurotrophic factors. Outside of the eye, caveolins play essential roles in preconditioning, pro-survival signaling, and neuronal protection. They amplify the secretion of neuroprotective cytokines such as leukemia inhibitory factor (LIF), an important retinal neurotroph. We hypothesize that Caveolin-1 (Cav1) in the retina is required for retinal neuroprotection. This mini-review summarizes findings on the cytoprotective roles of Cav1 and how it may be required for retinal neuroprotection.</p>","PeriodicalId":7270,"journal":{"name":"Advances in experimental medicine and biology","volume":"1468 ","pages":"287-291"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143389743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Extracellular Matrix Gene Expression Patterns in Retinal Wound Healing: A Comparative Study Between Mouse and Zebrafish Laser Injury Models.","authors":"Laura Jahnke, Volker Enzmann","doi":"10.1007/978-3-031-76550-6_35","DOIUrl":"10.1007/978-3-031-76550-6_35","url":null,"abstract":"<p><p>Fibrosis is an outcome of irregular wound healing, manifesting as heightened scar formation marked by substantial extracellular matrix (ECM) accumulation, persistent inflammation, and gradual tissue or organ restructuring. This condition disrupts the normal tissue architecture, impairing organ function. Herein, the pivotal role of fibrosis in retinal repair mechanisms is compared in mice and zebrafish in responses to laser-induced injury. Our focus spans the intricate interplay between the gene regulation of ECM-involved protagonists and the dynamic development of fibrotic scars. We observed differential gene expression shifts and evaluated the effects of the fibrosis inhibitor pirfenidone (PFD) in the mouse model. These insights into retinal repair mechanisms contribute to a comprehensive understanding, guiding future therapeutic strategies for vision preservation.</p>","PeriodicalId":7270,"journal":{"name":"Advances in experimental medicine and biology","volume":"1468 ","pages":"213-217"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143389600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Unveiling the Research Void: Exploring the Reproductive Effects of PFAS Compounds on Male Health.","authors":"Haoyang Qu, Yating Han, Chenglu Wang, Dongwang Zheng, Ya Ni, Xiang Xiao","doi":"10.1007/978-3-031-82990-1_7","DOIUrl":"https://doi.org/10.1007/978-3-031-82990-1_7","url":null,"abstract":"<p><p>Per- and polyfluoroalkyl substances (PFAS) represent an emerging concern for male reproductive health. Epidemiological studies have reported associations between increased PFAS exposure and reduced semen quality parameters, lower sperm counts, and potential alterations in reproductive hormone levels. Toxicology research has revealed possible mechanisms including blood-testis barrier disruption, oxidative stress, interference with testicular cell function, and epigenetic changes. However, significant uncertainties remain regarding definitive exposure-response relationships, developmental windows of heightened vulnerability, combined mixture effects, and causality interpretation, given limitations inherent to observational studies. Ongoing investigation of short-chain and replacement PFAS compounds is also critically needed. Additionally, directly connecting the mechanistic insights from animal models to human fertility impacts remains challenging. While controlled toxicology studies have described pathways by which PFAS could impair cellular functioning in the testes, uncertainty persists in extrapolating these experimental effects to real-world human exposures and sperm parameter declines reported epidemiologically. Overall, current findings suggest PFAS may contribute to declining male reproductive function, but additional clarification through well-designed longitudinal cohort studies integrated with mechanistic animal work is still warranted to confirm exposure-fertility links across a range of PFAS types and inform evidence-based public health mitigation strategies.</p>","PeriodicalId":7270,"journal":{"name":"Advances in experimental medicine and biology","volume":"1469 ","pages":"127-162"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143956067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Intraflagellar Transport (IFT) and Sperm Formation.","authors":"Yunhao Liu, Yu Fang, Opeyemi Dhikhirullahi, Ling Zhang, Zhibing Zhang","doi":"10.1007/978-3-031-82990-1_17","DOIUrl":"https://doi.org/10.1007/978-3-031-82990-1_17","url":null,"abstract":"<p><p>Intraflagellar transport (IFT) is a conserved mechanism for cilia formation. Twenty-two IFT components form the IFT-A complex (six components) and IFT-B complex (sixteen components). Driven by kinesin and dynein motor proteins, these IFT complexes are involved in the trafficking of proteins needed for cilia assembly by anterograde transport and retrograde transport. IFT core components also associate with other proteins for cilia formation. Mutations in IFT core components result in ciliogenesis defects and human diseases, including male infertility. Sperm flagella are specialized motile cilia that not only have core axoneme structure but also possess accessory structures. IFT is required to assemble these structures to form functional sperm. This summary highlights the regulatory roles of specific IFT proteins in spermatogenesis. A deeper understanding of IFT-related mechanisms can shed light on the etiology and pathophysiology of certain male infertility cases, as well as provide insights for the development of novel male contraceptives.</p>","PeriodicalId":7270,"journal":{"name":"Advances in experimental medicine and biology","volume":"1469 ","pages":"395-409"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143958152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Haoyang Qu, Qiubei Liu, Dongwang Zheng, Ya Ni, Xiang Xiao
{"title":"A Comprehensive Bibliometric Analysis of Orchitis Research from 1980 to 2023.","authors":"Haoyang Qu, Qiubei Liu, Dongwang Zheng, Ya Ni, Xiang Xiao","doi":"10.1007/978-3-031-82990-1_10","DOIUrl":"https://doi.org/10.1007/978-3-031-82990-1_10","url":null,"abstract":"<p><p>Orchitis, an inflammation of the testes, presents significant implications for male fertility and has been a focal area of scientific inquiry over the past four decades. This study employs a comprehensive bibliometric analysis to assess the progression of global research on orchitis from 1980 to 2023. Drawing from a dataset of 1586 publications indexed in the Web of Science Core Collection, we uncover emerging patterns, collaborations, and pivotal works that have shaped the field. The United States, China, and Germany emerge as leading contributors, while the Journal of Urology stands out as a primary publishing avenue. The results highlight the increasing recognition of autoimmune responses, alongside infectious agents, as key contributors to orchitis. Moreover, molecules such as TNF-α, IL-6, and IFN-γ are identified as central to the disease's pathology. The dynamic interplay of testosterone and regulatory T cells is underscored as a determinant of the testicular immune milieu. Notably, disruptions in the blood-testis barrier (BTB) and germ cell apoptosis emerge as pivotal consequences of the condition. This analysis underscores the expansive and multidisciplinary nature of orchitis research, revealing a consistent growth in collaborative endeavors. In summary, our findings catalog the evolution of orchitis research, providing a consolidated perspective on past achievements and signposting future research avenues. Such insights are instrumental for researchers aiming to navigate the complexities of orchitis and its multifaceted impact on male reproductive health.</p>","PeriodicalId":7270,"journal":{"name":"Advances in experimental medicine and biology","volume":"1469 ","pages":"207-243"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143965872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"MicroRNAs Fine-Tune Brain and Body Communication in Health and Disease : MicroRNAs in Brain-Body Communication.","authors":"David C Henshall","doi":"10.1007/978-3-031-89525-8_12","DOIUrl":"https://doi.org/10.1007/978-3-031-89525-8_12","url":null,"abstract":"<p><p>MicroRNAs are short noncoding RNAs that post-transcriptionally regulate gene expression. Their function is to fine-tune protein levels, thereby reducing gene expression noise. MicroRNAs serve critical functions during brain development, sculpting the transcript landscapes that direct cell proliferation, migration, and differentiation. In the mature brain, microRNAs impose stability on gene expression patterns to protect the constancy of network behavior while also facilitating the mechanics of synaptic plasticity. Brain diseases feature alterations in levels of specific microRNAs which influence injury and repair processes including changes to neuronal and glia morphology, immune and inflammatory responses, and cellular metabolism. MicroRNAs are also found within the extracellular space, including circulating in the cerebrospinal fluid and plasma. Characterization of biofluid microRNAs indicates some have CNS origins leading to the idea that microRNAs function in local and long-distance signalling. This chapter reviews the microRNA pathway and functions in the brain, the physical forms of extracellular microRNAs including encapsulation within extracellular vesicles, the changes to circulating microRNAs in brain diseases and evidence that circulating microRNAs come from the brain, and the effects, if any, of extracellular microRNA on recipient cells. The chapter also reviews the clinical applications of these findings, including diagnostic point-of-care testing and as therapeutic targets.</p>","PeriodicalId":7270,"journal":{"name":"Advances in experimental medicine and biology","volume":"1477 ","pages":"311-337"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144180675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Connection Between the Appetite-Regulatory Peptides Ghrelin and GLP-1 and Alcohol Use Disorder.","authors":"Elisabet Jerlhag","doi":"10.1007/978-3-031-89525-8_8","DOIUrl":"https://doi.org/10.1007/978-3-031-89525-8_8","url":null,"abstract":"<p><p>The body-brain connection is well-established, further evidenced by studies on the orexigenic peptide ghrelin and the anorexigenic peptide glucagon-like peptide-1 (GLP-1). The ghrelin pathway consists of several substrates, which has been studied in relation to alcohol-related responses. Preclinical studies have found that central ghrelin infusions elevate alcohol intake, whereas suppression of the ghrelin receptors (GHSR) attenuates alcohol-related responses. On a similar note, the endogenous GHSR inverse agonist, LEAP2, and the precursor of ghrelin, DAG, block the stimulatory properties of alcohol and reduce alcohol intake. GLP-1 receptor agonists are currently approved for the treatment of type 2 diabetes and obesity. Recent advances in rodents have extended the pharmacological relevance of these GLP-1 receptor agonists as they mitigate alcohol-related responses. Specifically, in animal models reflecting alcohol use disorder (AUD) all tested GLP-1 receptor agonists reduce alcohol intake, suppress the motivation to consume alcohol, and prevent relapse drinking, effects most likely driven by an attenuation of alcohol-induced reward. Additional experiments were conducted in attempts to define areas and circuits responsible for ghrelin and GLP-1 to control alcohol-related responses. Specifically, areas associated with reward were defined as important modulatory areas. In summary, the ghrelin pathway and GLP-1 participate in the pathophysiology of AUD, thereby providing tentative treatment targets.</p>","PeriodicalId":7270,"journal":{"name":"Advances in experimental medicine and biology","volume":"1477 ","pages":"229-241"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144179696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohammed Essa, Mohsen Alzahrani, Ali D Alahmari, Mahmoud Aljurf
{"title":"Hematopoietic Stem Cell Transplantation in Sickle Cell Disease.","authors":"Mohammed Essa, Mohsen Alzahrani, Ali D Alahmari, Mahmoud Aljurf","doi":"10.1007/978-3-031-84988-6_10","DOIUrl":"https://doi.org/10.1007/978-3-031-84988-6_10","url":null,"abstract":"<p><p>Sickle cell disease (SCD) is the most common inherited hemoglobinopathy worldwide with more than 300,000 babies in the world born every year with this disease. The clinical presentation and severity can be variable depending on many factors such as disease genotype, geographical location, environmental factors, and inheritance of other genetic abnormalities. The survival of patients with SCD have improved over last 3 decades where the expected median survival is more than 50 years for patients living in the developed countries. This improved survival is secondary to simple prophylactic and therapeutic interventions such as blood transfusions, prophylactic antibiotics, and vaccination. Disease modifying agents such as hydroxyurea contributed to the improved all disease outcome, survival, and quality of life. Over last 2 decades, curative options such as allogeneic stem cell transplant have gained popularity and increased evidence of safety and efficacy as the only curative option for SCD. However, there are many challenges to consider in patients who undergo hematopoietic stem cell transplantation (HSCT) that may affect the outcome. In this chapter, multiple challenges will be discussed including the indications of HSCT, choosing the appropriate donor and how to prevent and manage the unique or common post-transplant complications. Elaborative sections will focus on conditioning regimens choices in matched related donor HSCT. In addition, challenges in regards to various approaches of alternative donor transplant will be thoroughly discussed. Finally, long term effects and recommended follow up will be described.</p>","PeriodicalId":7270,"journal":{"name":"Advances in experimental medicine and biology","volume":"1475 ","pages":"177-191"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144245646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}